[go: up one dir, main page]

BRPI0817230A2 - vacina contra influenza inativada, e, uso da vacina - Google Patents

vacina contra influenza inativada, e, uso da vacina

Info

Publication number
BRPI0817230A2
BRPI0817230A2 BRPI0817230A BRPI0817230A BRPI0817230A2 BR PI0817230 A2 BRPI0817230 A2 BR PI0817230A2 BR PI0817230 A BRPI0817230 A BR PI0817230A BR PI0817230 A BRPI0817230 A BR PI0817230A BR PI0817230 A2 BRPI0817230 A2 BR PI0817230A2
Authority
BR
Brazil
Prior art keywords
vaccine
inactivated influenza
influenza vaccine
inactivated
influenza
Prior art date
Application number
BRPI0817230A
Other languages
English (en)
Portuguese (pt)
Inventor
Lodewijk Glansbeek Henricus
Gerardus Maria Heldens Jacobus
Original Assignee
Nobilon Int B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobilon Int B V filed Critical Nobilon Int B V
Publication of BRPI0817230A2 publication Critical patent/BRPI0817230A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0817230A 2007-09-24 2008-09-23 vacina contra influenza inativada, e, uso da vacina BRPI0817230A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97456807P 2007-09-24 2007-09-24
EP07117050 2007-09-24
PCT/EP2008/062694 WO2009040343A1 (en) 2007-09-24 2008-09-23 Inactivated influenza vaccine

Publications (1)

Publication Number Publication Date
BRPI0817230A2 true BRPI0817230A2 (pt) 2017-06-06

Family

ID=39590199

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817230A BRPI0817230A2 (pt) 2007-09-24 2008-09-23 vacina contra influenza inativada, e, uso da vacina

Country Status (6)

Country Link
EP (1) EP2195020A1 (es)
CN (1) CN101808659A (es)
AR (1) AR068536A1 (es)
BR (1) BRPI0817230A2 (es)
TW (1) TW200927928A (es)
WO (1) WO2009040343A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9278999B2 (en) 2012-01-27 2016-03-08 Newport Laboratories Influenza C virus and vaccine
CA2954740C (en) 2014-07-11 2022-10-18 National Research Council Of Canada Sulfated-glycolipids as adjuvants for vaccines
CN104792985A (zh) * 2015-04-21 2015-07-22 乾元浩生物股份有限公司 定性定量分析禽用禽流感病毒抗原有效成分的方法
CA3083576A1 (en) * 2017-09-07 2019-03-14 Hawaii Biotech, Inc. Filovirus vaccine and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
US20090304742A1 (en) * 2005-11-04 2009-12-10 Novartis Vaccines And Diagnostics Srl Influenza vaccines with reduced amount of emulsion adjuvant

Also Published As

Publication number Publication date
AR068536A1 (es) 2009-11-18
TW200927928A (en) 2009-07-01
CN101808659A (zh) 2010-08-18
WO2009040343A1 (en) 2009-04-02
EP2195020A1 (en) 2010-06-16

Similar Documents

Publication Publication Date Title
IL186611A0 (en) Vaccine against pandemic strains of influenza viruses
PL2281830T3 (pl) Szczepionka przeciw wirusowi ospy wietrznej i półpaśca
BRPI1011916A2 (pt) uso de uma combinação de filtro uv, e, preparação cosmética.
BR112012003792A2 (pt) gel tópico, e, uso do gel tópico.
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0919014A2 (pt) composição fixadora de cabelo, e, uso de uma composição
BR112012013148A2 (pt) formulação farmacêutica e uso
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
EA201070219A1 (ru) Полимерные мультиэпитопные вакцины против гриппа
AP2008004625A0 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
DK2069503T3 (da) Papayamosaikvirus-baserede vacciner mod influenza
HUE043952T2 (hu) Módosított influenzavírus vakcinahatékonyság monitorozására és javítására
BRPI0914069A2 (pt) composição de vacina para uso contra o influenza
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0921359A2 (pt) Antígenos que induzem a resposta imunológica contra flavivírus e métodos de uso dos mesmos
CR10571A (es) Vacuna virica recombinante
BRPI0821034A2 (pt) Vírus influenza modificado
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
ZA200809056B (en) Influenza virus vaccine
EP2125500A4 (en) HIV COMBINED VACCINE AND METHOD OF PRIMO VACCINATION / REMINDER
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
PT2408913T (pt) Péptidos neil3 e vacinas que incluem os mesmos
DK2422810T3 (da) Influenzavaccine
BRPI0815373A2 (pt) Derivados de ciclo-hexeno e o uso dos mesmos como fragrâncias
BRPI1014904A2 (pt) derivados de quinazolinadiona, preparação dos mesmos e vários usos terapêuticos dos mesmos.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)